199
Views
0
CrossRef citations to date
0
Altmetric
Review

Pharmacological approaches to the management of panic disorder in older patients: a systematic review

, , , &
Pages 1013-1029 | Received 14 Jun 2023, Accepted 30 Aug 2023, Published online: 07 Sep 2023

References

  • American Psychiatric Association. Diagnostic and statistical manual of mental disorders fifth Edition [Internet]. American psychiatric Association, editor. Arlington (VA): American Psychiatric Association; 2013. Available from. doi: 10.1176/appi.books.9780890425596
  • de Jonge P, Roest AM, Lim CCW, et al. Cross-national epidemiology of panic disorder and panic attacks in the world mental health surveys. Depress Anxiety Internet. 2016 [cited 2021 Jan 24];33(12):1155–1177. doi: 10.1002/da.22572
  • Hendriks SM, Spijker J, Licht CMM, et al. Long-term disability in anxiety disorders. BMC Psychiatry. Internet. 2016 [cited 2023 Feb 21];16(1): doi: 10.1186/s12888-016-0946-y
  • Meuret AE, Tunnell N, Roque A. Anxiety disorders and medical comorbidity: treatment implications. Adv Exp Med Biol Internet. 2020 [cited 2023 Feb 7];1191:237–261. https://pubmed.ncbi.nlm.nih.gov/32002933/
  • Brettschneider C, Bleibler F, Hiller TS, et al. The allocation of resources in the care for patients with panic disorder in Germany: an excess cost analysis informing policy and science. Cost Eff Resour Alloc. Internet. 2019 [cited 2021 Jan 24];17(1): doi: 10.1186/s12962-019-0177-4
  • Bandelow B, Michaelis S. Epidemiology of anxiety disorders in the 21st century. Dialogues Clin Neurosci Internet . 2015 [cited 2023 May 10]; 17(3):327–335. doi: 10.31887/DCNS.2015.17.3/bbandelow
  • Van Loo HM, Beijers L, Wieling M, et al. Prevalence of internalizing disorders, symptoms, and traits across age using advanced nonlinear models. Psychol Med Internet. 2023 [cited 2023 May 10];53(1):78–87. doi: 10.1017/S0033291721001148
  • Kessler RC, Petukhova M, Sampson NA, et al. Twelve-month and lifetime prevalence and lifetime morbid risk of anxiety and mood disorders in the United States. Int J Methods Psychiatr Res Internet. 2012 [cited 2022 Feb 1];21(3):169–184. doi: 10.1002/mpr.1359
  • Seguí J, Salvador-Carulla L, Márquez M, et al. Differential clinical features of late-onset panic disorder. J Affect Disord Internet. 2000 [cited 2023 Jun 7];57(1–3):115–124. doi: 10.1016/S0165-0327(99)00082-8
  • Raj BA, Corvea MH, Dagon EM. The clinical characteristics of panic disorder in the elderly: a retrospective study. J Clin Psychiatry. 1993;54(4):150–155.
  • UN Decade of Healthy Aging: Plan of Action 2021-2030 [Internet]. cited 2023 May 29. Available from: https://cdn.who.int/media/docs/default-source/decade-of-healthy-ageing/decade-proposal-final-apr2020-en.pdf?sfvrsn=b4b75ebc_28
  • Stein MB, Marcia Goin CK, Pollack MH, et al. Practice guideline for the treatment of patients with panic disorder second edition work group on panic disorder steering committee on practice guidelines. 2010 cited 2023 May 29. Available from: http://www.psychiatryonline.com/pracGuide/pracGuideTopic_9.aspx
  • Overview | Generalised anxiety disorder and panic disorder in adults: management | Guidance | NICE [Internet]. [cited 2023 May29];https://www.nice.org.uk/guidance/CG113
  • Bandelow B, Allgulander C, Baldwin DS, et al. World Federation of Societies of biological Psychiatry (WFSBP) guidelines for treatment of anxiety, obsessive-compulsive and posttraumatic stress disorders - Version 3. Part I: Anxiety disorders. World J Biol Psychiatry Internet. 2022 [cited 2022 Jul 29];1–39. https://pubmed-ncbi-nlm-nih-gov.ezproxy.ub.unimaas.nl/35900161/.
  • Bandelow B, Werner AM, Kopp I, et al. The German guidelines for the treatment of anxiety disorders: first revision. Eur Arch Psychiatry Clin Neurosci Internet. 2022 [cited 2023 May 29];272(4):571–582. doi: 10.1007/s00406-021-01324-1
  • Bandelow B, Schüller K. Mean age and gender distribution of patients with major mental disorders participating in clinical trials. Eur Arch Psychiatry Clin Neurosci Internet . 2020 [cited 2023 Jun 6]; 270(6):655–659. doi: 10.1007/s00406-018-0972-5
  • Corsonello A, Pedone C, Incalzi R. Age-related pharmacokinetic and pharmacodynamic changes and related risk of adverse drug reactions. Curr Med Chem Internet . 2010 [cited 2023 Jun 7]; 17(6):571–584. doi: 10.2174/092986710790416326
  • Bowie MW, Slattum PW. Pharmacodynamics in older adults: a review. Am J Geriatr Pharmacother Internet . 2007 [cited 2023 Jun 7]; 5(3):263–303. doi: 10.1016/j.amjopharm.2007.10.001
  • Singh S, Bajorek B. Pharmacotherapy in the ageing patient: The impact of age per se (A review). Ageing Res Rev Internet. 2015 [cited 2023 Jun 7];24:99–110. doi: 10.1016/j.arr.2015.07.006
  • Davies SJC, Eayrs S, Pratt P, et al. Potential for drug interactions involving cytochromes P450 2D6 and 3A4 on general adult psychiatric and functional elderly psychiatric wards. Br J Clin Pharmacol. 2004;57(4):464. doi: 10.1111/j.1365-2125.2003.02040.x
  • Katerndahl DA, Talamantes M. A comparison of persons with early-versus late-onset panic attacks. J Clin Psychiatry Internet . 2000 [cited 2023 Jun 7]; 61(6):422–427. doi: 10.4088/JCP.v61n0606
  • Sheikh JI, Swales PJ, Carlson EB, et al. Aging and panic disorder: Phenomenology, comorbidity, and risk factors. Am J Geriatr Psychiatry. 2004;12(1):102–109. doi: 10.1097/00019442-200401000-00013
  • Lenze EJ, Wetherell JL. A lifespan view of anxiety disorders. Dialogues Clin Neurosci Internet. 2011 [cited 2023 Jun 7];13(4):381–399. doi: 10.31887/DCNS.2011.13.4/elenze
  • Kuikka JT, Tammela L, Bergström KA, et al. Effects of ageing on serotonin transporters in healthy females. Eur J Nucl Med Internet. 2001 [cited 2023 May 10];28(7):911–913. doi: 10.1007/s002590100540
  • Lawlor BA, Sunderland T, Hill JL, et al. Evidence for a decline with age in behavioral responsivity to the serotonin agonist, m-chlorophenylpiperazine, in healthy human subjects. Psychiatry Res Internet. 1989 [cited 2023 Jun 7];29(1):1–10. doi: 10.1016/0165-1781(89)90181-9
  • Yamamoto M, Suhara T, Okubo Y, et al. Age-related decline of serotonin transporters in living human brain of healthy males. Life Sci Internet. 2002 [cited 2023 Jun 7];71(7):751–757. doi: 10.1016/S0024-3205(02)01745-9
  • Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ Internet. 2021 [cited 2022 Aug 5];372. https://pubmed.ncbi.nlm.nih.gov/33782057/
  • Bandelow B, Michaelis S, Wedekind D. Treatment of anxiety disorders. Dialogues Clin Neurosci Internet . 2017 [cited 2021 Jan 31]; 19(2):93–107. doi: 10.31887/DCNS.2017.19.2/bbandelow
  • Bandelow B. Current and novel psychopharmacological drugs for anxiety disorders. Adv Exp Med Biol InternetSpringer. 2020 [cited 2021 Jan 31];347–365. https://pubmed.ncbi.nlm.nih.gov/32002937/.
  • Higgins JPT, Altman DG, Gøtzsche PC, et al. The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. BMJ Internet. 2011 [cited 2023 May 19];343(oct18 2):d5928–d5928. doi: 10.1136/bmj.d5928
  • Hendriks GJ, Keijsers GPJ, Kampman M, et al. A randomized controlled study of paroxetine and cognitive-behavioural therapy for late-life panic disorder. Acta Psychiatrica Scandinavica Internet. 2010 [cited 2023 May 14];122(1):11–19. doi: 10.1111/j.1600-0447.2009.01517.x
  • Raffaele R, Vecchio I, Malaguarnera M, et al. Therapy of panic attacks in the elderly. Arch Gerontol Geriatr Suppl Internet. 2002 [cited 2023 May 14];8:295–301. doi: 10.1016/S0167-4943(02)00111-5
  • Rampello L, Alvano A, Raffaele R, et al. New possibilities of treatment for panic attacks in elderly patients: escitalopram versus citalopram. J Clin Psychopharmacol Internet. 2006 [cited 2023 May 14];26(1):67–70. doi: 10.1097/01.jcp.0000195383.96383.25
  • Sheikh JI, Lauderdale SA, Cassidy EL. Efficacy of sertraline for panic disorder in older adults: a preliminary open-label trial. American Journal Of Geriatric Psychiatry Internet. 2004 [cited 2023 May 14];12(2):230. doi: 10.1176/appi.ajgp.12.2.230
  • Nations UD of E and SA. World population ageing 2019 Highlights.
  • World Health Organization. Ageing and health [Internet]. https://cdn.who.int/media/docs/default-source/decade-of-healthy-ageing/decade-proposal-final-apr2020-en.pdf
  • Perna G, Iannone G, Alciati A, et al. Are anxiety disorders associated with accelerated aging? A focus on neuroprogression. Neural Plast. 2016;2016:1–19. doi: 10.1155/2016/8457612
  • Ding H, Zhong Y, Liu N, et al. Panic disorder aging characteristics: The role of telomerase reverse transcriptase gene and brain function. Front Aging Neurosci Internet. 2022 [cited 2023 Jun 9]; 14: doi: 10.3389/fnagi.2022.835963
  • American Psychiatric Association. Diagnostic and statistical manual of mental disorders. In American psychiatric assocIation. editor. 5th. Arlington (VA): American Psychiatric Association; 2013. doi: 10.1176/appi.books.9780890425596
  • Perna G, Caldirola D. Is panic disorder a disorder of physical fitness? A heuristic proposal. F1000Res Internet. 2018 [cited 2021 Jan 26];7:294. doi: 10.12688/f1000research.12788.1
  • Kampman M, Keijsers GPJ, Hoogduin CAL, et al. A randomized, double-blind, placebo-controlled study of the effects of adjunctive paroxetine in panic disorder patients unsuccessfully treated with cognitive-behavioral therapy alone. J Clin Psychiatry Internet. 2002 [cited 2023 Jun 10];63(9):772–777. doi: 10.4088/JCP.v63n0904
  • Payne LA, White KS, Gallagher MW, et al. Second-stage treatments for relative nonresponders to cognitive behavioral therapy (CBT) for panic disorder with or without agoraphobia-continued CBT versus SSRI: A randomized controlled trial. Depress Anxiety Internet. 2016 [cited 2023 Jun 10];33(5):392–399. doi: 10.1002/da.22457
  • Van Apeldoorn FJ, Van Hout WJPJ, Timmerman ME, et al. Rate of improvement during and across three treatments for panic disorder with or without agoraphobia: cognitive behavioral therapy, selective serotonin reuptake inhibitor or both combined. J Affect Disord Internet. 2013 [cited 2023 Jun 10];150:313–319. doi: 10.1016/j.jad.2013.04.012
  • Charlesworth CJ, Smit E, Lee DSH, et al. Polypharmacy among adults aged 65 years and older in the United States: 1988–2010. GERONA Internet. 2015 [cited 2023 Jun 11];70(8):989–995. doi: 10.1093/gerona/glv013
  • Lockery JE, Ernst ME, Broder JC, et al. Prescription medication use in older adults without major cardiovascular disease Enrolled in the Aspirin in reducing events in the elderly (ASPREE) clinical trial. Pharmacotherapy Internet. 2020 [cited 2023 Jun 11];40(10):1042–1053. doi: 10.1002/phar.2461
  • Coelho CM, Gonçalves DC, Purkis H, et al. Specific phobias in older adults: characteristics and differential diagnosis. Int Psychogeriatrics Internet. 2010 [cited 2023 Jun 7];22(5):702–711. doi: 10.1017/S1041610210000505
  • Goodwin RD, Eaton WW. Asthma and the risk of panic attacks among adults in the community. Psychol Med Internet . 2003 [cited 2021 Feb 14]; 33(5):879–885. doi: 10.1017/S0033291703007633
  • Caldirola D, Perna G. Toward a personalized therapy for panic disorder: preliminary considerations from a work in progress. Neuropsychiatr Dis Treat Internet. 2019 [cited 2021 Feb 14];15: 1957–1970. doi: 10.2147/NDT.S174433
  • Caldirola D, Schruers KR, Nardi AE, et al. Is there cardiac risk in panic disorder? An updated systematic review. J Affect Disord Internet. 2016 [cited 2022 Aug 4];194:38–49. doi: 10.1016/j.jad.2016.01.003
  • Eisner MD, Blanc PD, Yelin EH, et al. Influence of anxiety on health outcomes in COPD. Thorax Internet. 2010 [cited 2023 Feb 8];65(3):229–234. doi: 10.1136/thx.2009.126201
  • Gu ZH, Yang CX, Tang L, et al. Interaction of anxiety and hypertension on quality of life among patients with gynecological cancer: a cross-sectional study. BMC Psychiatry. Internet. 2023 [cited 2023 Feb 8];23(1): doi: 10.1186/s12888-023-04521-5
  • Pitman A, Suleman S, Hyde N, et al. Depression and anxiety in patients with cancer. BMJ Internet. 2018 [cited 2023 Feb 8];361:k1415. doi: 10.1136/bmj.k1415
  • Smaardijk VR, Maas AHEM, Lodder P, et al. Sex and gender-stratified risks of psychological factors for adverse clinical outcomes in patients with ischemic heart disease: a systematic review and meta-analysis. Int J Cardiol Internet. 2020 [cited 2023 Feb 8];302:21–29. doi: 10.1016/j.ijcard.2019.12.014
  • Caldirola D, Grassi M, Alciati A, et al. Personalized medicine in panic disorder: where are we now? A meta-regression analysis. Pers Med Psychiatry. 2017;1–2:26–38.
  • Perna G, Nemeroff CB. Personalized medicine in Psychiatry: back to the future. Pers Med Psychiatry Internet. 2017;1–2:1. doi: 10.1016/j.pmip.2017.01.001
  • Perna G, Alciati A, Sangiorgio E, et al. Personalized clinical approaches to anxiety disorders. Adv Exp Med Biol. 2020;1191:489–521.
  • Perna G, Grassi M, Caldirola D, et al. The revolution of personalized psychiatry: will technology make it happen sooner? [Internet]. Psychol Med Cambridge University Press. 2018 [cited 2021 Apr 9];48(5):705–713. doi: 10.1017/S0033291717002859
  • Griez EJ, Colasanti A, van Diest R, et al. Carbon dioxide inhalation induces dose-dependent and age-related negative affectivity. PLoS One Internet. 2007 [cited 2023 May 10];2(10):e987. doi: 10.1371/journal.pone.0000987
  • Flint AJ, Koszycki D, Vaccarino FJ, et al. Effect of aging on cholecystokinin-induced panic. Am J Psychiatry Internet. 1998 [cited 2023 Jun 7];155(2):283–285. doi: 10.1176/ajp.155.2.283
  • Rezaei K, Nami M, Sinaei E, et al. A comparison between effects of neurofeedback and balance exercise on balance of healthy older adults. J Biomed Phys Eng Internet. 2021 [cited 2023 Jun 11];11(6):713–722. doi: 10.31661/jbpe.v0i0.1203
  • Prado CE, Watt S, Crowe SF. A meta-analysis of the effects of antidepressants on cognitive functioning in depressed and non-depressed samples. Neuropsychol rev Internet . 2018 [cited 2023 Jun 11]; 28(1):32–72. doi: 10.1007/s11065-018-9369-5
  • Skandali N, Rowe JB, Voon V, et al. Dissociable effects of acute SSRI (escitalopram) on executive, learning and emotional functions in healthy humans. Neuropsychopharmacology Internet. 2018 [cited 2023 Jun 12];43(13):2645–2651. doi: 10.1038/s41386-018-0229-z
  • Lenze EJ, Dixon D, Nowotny P, et al. Escitalopram reduces attentional performance in anxious older adults with high-expression genetic variants at serotonin 2A and 1B receptors. Int J Neuropsychopharmacol Internet. 2013 [cited 2023 Jun 11];16(2):279–288. doi: 10.1017/S1461145712000351
  • Blumberg MJ, Vaccarino SR, McInerney SJ. Procognitive effects of antidepressants and other therapeutic agents in major depressive disorder: a systematic review. J Clin Psychiatry Internet. 2020 [cited 2023 Jun 11];81(4). doi: 10.4088/JCP.19r13200
  • Wang C, Gao S, Hendrie HC, et al. Antidepressant use in the elderly is associated with an increased risk of dementia. Alzheimer Dis Assoc Disord Internet. 2016 [cited 2023 Jun 11];30(2):99–104. doi: 10.1097/WAD.0000000000000103
  • Airaksinen E, Larsson M, Forsell Y. Neuropsychological functions in anxiety disorders in population-based samples: evidence of episodic memory dysfunction. J Psychiatr Res. 2005;39(2):207–214. doi: 10.1016/j.jpsychires.2004.06.001
  • Butters MA, Bhalla RK, Andreescu C, et al. Changes in neuropsychological functioning following treatment for late-life generalised anxiety disorder. Br J Psychiatry. 2011;199(3):211–218. doi: 10.1192/bjp.bp.110.090217
  • Gulpers BJA, Verhey FRJ, Eussen SJPM, et al. Anxiety and cognitive functioning in the Maastricht study: across-sectional population study. J Affect Disord. 2022;319:570–579. doi: 10.1016/j.jad.2022.09.072
  • Nyberg J, Henriksson M, Wall A, et al. Anxiety severity and cognitive function in primary care patients with anxiety disorder: a cross-sectional study. BMC Psychiatry. 2021;21(1):21. doi: 10.1186/s12888-021-03618-z
  • Harber L, Hamidian R, Bani-Fatemi A, et al. Meta-analysis of neuropsychological studies in panic disorder patients: evidence of impaired performance during the emotional stroop task. Neuropsychobiology Internet. 2019 [cited 2023 Jun 11];78(1):7–13. doi: 10.1159/000496623
  • Alves MRP, Pereira VM, Machado S, et al. Cognitive functions in patients with panic disorder: a literature review. Rev Bras Psiquiatr Internet. 2013 [cited 2023 Jun 11];35(2):193–200. doi: 10.1590/1516-4446-2012-1000
  • Sinoff G, Werner P. Anxiety disorder and accompanying subjective memory loss in the elderly as a predictor of future cognitive decline. Int J Geriatr Psychiatry Internet . 2003 [cited 2023 Jun 11]; 18(10):951–959. doi: 10.1002/gps.1004
  • Gallagher E, Mehmood M, Lavan A, et al. Psychotropic medication use and future unexplained and injurious falls and fracture amongst community-dwelling older people: data from TILDA. Eur Geriatr Med Internet. 2023 [cited 2023 Jun 11];14(3):455–463. doi: 10.1007/s41999-023-00786-x
  • Newgard CD, Lin A, Caughey AB, et al. Falls in older adults requiring emergency services: mortality, use of healthcare resources, and prognostication to one year. West J Emerg Med Internet. 2022 [cited 2023 Jun 11];23(3):375–385. doi: 10.5811/westjem.2021.11.54327
  • By the 2023 American Geriatrics Society Beers Criteria® Update Expert Panel. American Geriatrics Society 2023 updated AGS Beers criteria® for potentially inappropriate medication use in older adults. J Am Geriatr Soc Internet. 2023 [cited 2023 Jun 11];71(7):2052–2081. doi: 10.1111/jgs.18372
  • Hiemke C, Härtter S. Pharmacokinetics of selective serotonin reuptake inhibitors. Pharmacol Ther Internet . 2000 [cited 2023 Jun 11]; 85(1):11–28. doi: 10.1016/S0163-7258(99)00048-0
  • De Vane CL, Liston HL, Markowitz JS. Clinical pharmacokinetics of sertraline. Clin Pharmacokinet. 2002;41(15):1247–1266. doi: 10.2165/00003088-200241150-00002
  • Stahl SM. Stahl’s essential psychopharmacology [Internet]. Cambridge University Press; 2021. [[cited 2023 Aug 24]]; Available from: https://www.cambridge.org/core/product/identifier/9781108975292/type/book
  • Torous J, Bucci S, Bell IH, et al. The growing field of digital psychiatry: current evidence and the future of apps, social media, chatbots, and virtual reality. World Psychiatry Internet. 2021 [[cited 2022 Aug 4]];20(3):318–335. doi: 10.1002/wps.20883

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.